title: Inflammatory depression: a trifecta of trouble.
authors.affiliation: University of Arizona, Frances McClelland Institute, Tucson, AZ 85724 craison@email.arizona.edu.
authors.forename: Charles L
authors.initials: CL
authors.lastname: Raison
mesh_terms: D000328:Adult; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects / Q000276:immunology; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology* / Q000523:psychology; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D004660:Encephalitis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology* / Q000523:psychology; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects / Q000276:immunology; D018836:Inflammation Mediators / Q000097:blood*; D000069285:Infliximab; D008016:Life Change Events; D017628:Microglia / Q000187:drug effects / Q000276:immunology; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000928:Antidepressive Agents; D018836:Inflammation Mediators; D000069285:Infliximab